Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088929 · ClinicalTrials.gov registry record · Phase 2
The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy
A Phase 2 study of Diabetic Neuropathies, sponsored by Pure Green.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT04088929 is a Phase 2 study of Diabetic Neuropathies that has completed, run by Pure Green. The registered enrollment target is 32 participants, below the 324-participant average among 8 other Diabetic Neuropathies trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04088929, a Phase 2 study of Diabetic Neuropathies, has completed, sponsored by Pure Green.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Use of Cannabidiol for the treatment of Diabetic Neuropathic Pain.
Conditions Studied
Interventions
- DRUG CBD
Study Locations (1)
Michigan
- Dr. Nakadar's Office - Sterling Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2019-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04088929
The ClinicalTrials.gov registry entry for NCT04088929 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 324-participant average among 8 other Diabetic Neuropathies trials with a reported enrollment target (90% lower). The listed sponsor is Pure Green, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Neuropathies appearing as the primary indexed condition, and to 1 intervention - of which CBD is the first listed.
NCT04088929 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04088929 about?
NCT04088929 is a clinical study titled "The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy". Use of Cannabidiol for the treatment of Diabetic Neuropathic Pain.
What is the current status of trial NCT04088929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2019-09-30. Estimated completion is 2019-12-01.
What conditions does trial NCT04088929 study?
This clinical trial studies the following conditions: Diabetic Neuropathies.
What interventions are being tested in trial NCT04088929?
The interventions under investigation include: CBD (DRUG).
Who is sponsoring clinical trial NCT04088929?
This trial is sponsored by Pure Green, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04088929 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Neuropathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
COMPLETED · Phase 2
-
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
COMPLETED · Phase 2
-
Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
RECRUITING · Phase 1
-
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
COMPLETED
-
Treatment of Peripheral Neuropathy in Patients With Diabetes
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.